We have been working hard to address the threat of tariffs on medical technologies & emphasize the impacts they would have on health care. Global News highlighted these potential impacts, as well as the work of our association to try to address them.

Today our association released the following statement from our President and CEO, @nicole_dekort , on the continued tariff and sanction threat facing Canada and the need for a "Zero-for Zero" approach to tariffs on medical technologies: https://t.co/Vmc5HjOhRr

Abbott's Latest-Generation FreeStyle Libre 3 Plus Glucose Sensor Technology Launches in Canada @AbbottNews

Good public policy from @MBGov Canada's medical technology sector applauds this announcement - in particular the development of a clinical trials office intended to make it easier and more efficient to do health research in Manitoba - @Medtech_Canada members are ready 2 collab!

Incredible story that highlights the positive impact medical technologies can have on the lives of children and families! Kudos to @LHSCCanada and the clinicians involved for making this happen.

Health Canada approves Abbott's i-STAT TBI test for suspected concussions The authorisation extends the test's utility to assess individuals up to 24 hours post-injury. https://t.co/8NJEr5hc4R

@Providence_Hlth St. Paul's II is the largest hospital redevelopment in western Cda w/ 2 towers, 1.5 million sqft, 518 patients, $4.2 billion & slated 4 completion in 2027 it will be the most digitally integrated campus in Western CDA - @Medtech_Canada are playing a big part!

In the final session of Canada's Regulatory & Quality Medtech Conference 2025, Stephan Meyer (ISED) and Nicolas Desmarais (ISED) from Innovation, Science and Economic Development Canada provided an overview of the wireless equipment certification process.

In this session, Tatjana Sachse (Association of British HealthTech Industries) explored the role of the World Health Organization (WHO) in shaping international regulatory standards, including MDSAP recognition and UK MHRA alignment.

In this session, Scott Sardeson (St. Cloud State University) provides valuable insights into the future of ISO 13485, including updates based on the latest systematic review outcomes that could have a tangible impact on compliance strategy and global market access.

In another panel at Canada's Regulatory & Quality Medtech Conference 2025, Marcin Boruk (Health Canada) and La-Toya Salmon, MBA, RAC (Abbott) discussed the Public Release of Clinical Information project, with Seema Vyas (Medtronic) moderating.

In this informative session, Bruce Calder (Claigan Environmental) provided a high-level breakdown of the Canadian Plastics Registry, focusing on industry-relevant features of the system.

This panel discussion featuring Lisa Schellenberg (Solventum) and George Kendros (ECCC), moderated by Mia Spiegelman BSc, RAQC (Medtech Canada), focused on the topic of balancing environmental concerns with access to healthcare products.

The third and final day of Canada's Regulatory & Quality Medtech Conference 2025 is off to a great start with George Kendros (Environment & Climate Change Canada) providing a helpful update on plastics and PFAS regulations.

The second day of the conference has wrapped up with an engaging Q&A session featuring all of the day's keynote and panel speakers. This interactive session provided attendees of Canada's Regulatory & Quality Medtech Conference 2025 the opportunity to ask any questions.

In this session, Mia Spiegelman (Medtech Canada), Amelia Swanson (Medtech Canada), Rob Pankhurst (Medtech Canada), Olivier Bourbeau (Medtech Canada), Raj Malik (Medtech Canada), and Sandra Leffler (Leffler Consulting) provided an overview of Medtech Canada's advocacy efforts.

Beginning the afternoon at Canada's Regulatory & Quality Medtech Conference 2025, Germaynne Gibson (Alcon), Michael Frosina (ConMed), and Adrian Jess (ConMed) explored key challenges and best practices in medical device servicing and installation from an industry perspective.

In the last session before the lunch break at Canada's Regulatory & Quality Medtech Conference 2025, Marie-Odile Gomis (Health Canada) and Barbara Morgan (Health Canada) provided a brief, informative overview of MDEL applications, recent updates, and key changes.

This session, featuring Ladan Rabieymotemaen (Health Canada), provided an excellent run-through of the Medical Devices Compliance Verification Program, covering key aspects such as triaging complaints and recalls, compliance verification tools, and regulatory expectations.

Returning from the first break of the second day, Dheeman Vaydia (IQVIA) and Mia Spiegelman (Medtech Canada) addressed the latest developments in medical device shortages, including insights from recent consultations, ongoing initiatives, and industry perspectives.

Prior to the first break of the day, attendees were given the opportunity to ask questions to each of the speakers featured in this morning's sessions. This open forum allowed attendees to dive deeper into topics, clarify points of interest, and engage in meaningful discussions.